EUSA Pharma Names Industry Veterans to Newly Created Posts

EUSA Pharma names industry veterans to newly-created posts

UK and USA-based specialty drugmaker EUSA Pharma today announced the strengthening of its senior leadership… To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.

Curating a Career: Carsten Thiel’s Purposeful Exploration of Pharma

Curating a Career: Carsten Thiel’s Purposeful Exploration of Pharma – Doug Sandler Blog

Through an average career cycle, one can ebb and flow with the change of tides, finding themselves accidentally in various positions. With just enough sheer luck, one may even find advancement in a given field, acquiring just enough knowledge, insight, and experience required to perform all required

 

EUSA Gains New President, Carsten Thiel Gains New Perspective

EUSA Gains New President, Carsten Thiel Gains New Perspective

EUSA Pharma, the global specialized pharmaceutical giant focused on treatment and cure of rare diseases, along with oncology care, has recently announced the newest appointment to their impressive management. Carsten Thiel, the world renowned leader within the realm of biopharmaceutical marketing, has been carefully selected to serve as the company’s President Europe, making this a new venture for the pharmaceutical veteran.

Carsten Thiel: People on The Move – New York Business Journal

Carston Thiel | People on The Move – New York Business Journal

Newly appointed President Europe of rapidly expanding global specialized pharmaceutical giant EUSA, which focuses on treatment and cure of rare diseases and oncology care, Carsten Thiel brings over twenty years of pertinent experience within the pharmaceutical sector to his new role.

 

Carsten Thiel: Impactful Medicine

Carsten Thiel: Impactful Medicine – Medical Daily Times

As a visionary within the realm of biotechnology, Carsten Thiel’s leadership, expertise, and professional experience has been parlayed into the successful launch of various high-profile medical products, such as Strensiq, Prolia, Vectibix and Neulasta. Not only has he spearheaded the market launch of many medical breakthrough therapies, but his direct involvement has improved the lives of thousands of patients.

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

HEMEL HEMPSTED, England and BOSTON, May 15, 2019 /PRNewswire/ — EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease,…

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development | Markets Insider

HEMEL HEMPSTED, England and BOSTON, May 15, 2019 /PRNewswire/ — EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announced the strengthening of its senior leadership team with the appointments of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development.

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

EUSA Pharma Announces Appointment of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development

HEMEL HEMPSTED, England and BOSTON, May 15, 2019 /PRNewswire/ — EUSA Pharma (EUSA), a global biopharmaceutical company focused on oncology and rare disease, today announced the strengthening of its senior leadership team with the appointments of Carsten Thiel as President Europe and Darrel P. Cohen as Head of Clinical Development.

EUSA Pharma bolsters senior leadership team with two appointments

EUSA Pharma bolsters senior leadership team with two appointments

Published on: 15/05/19 Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr Carsten Thiel as President Europe and Dr Darrel P Cohen as Head of Clinical Development. In his new role, Dr Thiel will be responsible for leading EUSA’s growing commercial infrastructure in Europe.